Neurones (NRO) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.05x
Neurones (NRO) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting €3.64 Million (capex €3.64 Million ) from operating cash flow of €67.10 Million. Check NRO cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.05x
(Capex + Investments) / Operating CF
Total Reinvested
€3.64 Million
Capex + Investments
Operating Cash Flow
€67.10 Million
EUR
Capital Expenditures
€3.64 Million
EUR
Neurones Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Neurones across 26 annual periods. Explore Neurones (NRO) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Neurones (2000–2025)
Year-by-year capital reinvestment analysis for Neurones. For live market cap and broader valuation context, see market value of Neurones.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | €10.44 Million | €80.77 Million | €10.44 Million | ▼ -65.6% |
| 2024 | 0.38x | €31.73 Million | €84.38 Million | €12.04 Million | ▼ -31.5% |
| 2023 | 0.55x | €39.55 Million | €72.08 Million | €17.98 Million | ▲ +31.9% |
| 2022 | 0.42x | €22.86 Million | €54.97 Million | €10.61 Million | ▲ +56.0% |
| 2021 | 0.27x | €17.20 Million | €64.50 Million | €6.58 Million | ▲ +121.1% |
| 2020 | 0.12x | €8.12 Million | €67.29 Million | €7.19 Million | ▼ -53.9% |
| 2019 | 0.26x | €16.04 Million | €61.32 Million | €7.89 Million | ▼ -50.4% |
| 2018 | 0.53x | €16.38 Million | €31.06 Million | €6.95 Million | ▼ -34.8% |
| 2017 | 0.81x | €18.82 Million | €23.27 Million | €8.96 Million | ▼ -13.6% |
| 2016 | 0.94x | €19.75 Million | €21.10 Million | €8.55 Million | ▲ +52.8% |
| 2015 | 0.61x | €18.41 Million | €30.05 Million | €12.85 Million | ▲ +185.5% |
| 2014 | 0.21x | €6.13 Million | €28.60 Million | €5.31 Million | ▼ -29.1% |
| 2013 | 0.30x | €6.06 Million | €20.02 Million | €5.50 Million | ▲ +29.4% |
| 2012 | 0.23x | €4.50 Million | €19.24 Million | €4.50 Million | ▼ -60.3% |
| 2011 | 0.59x | €4.89 Million | €8.30 Million | €4.89 Million | ▲ +209.2% |
| 2010 | 0.19x | €2.82 Million | €14.79 Million | €2.82 Million | ▲ +35.8% |
| 2009 | 0.14x | €2.19 Million | €15.60 Million | €2.19 Million | ▲ +1.2% |
| 2008 | 0.14x | €2.32 Million | €16.71 Million | €2.32 Million | ▼ -10.1% |
| 2007 | 0.15x | €2.37 Million | €15.35 Million | €2.37 Million | ▼ -67.1% |
| 2006 | 0.47x | €1.97 Million | €4.21 Million | €1.97 Million | ▲ +213.8% |
| 2005 | 0.15x | €833.00K | €5.58 Million | €833.00K | ▼ -1.8% |
| 2004 | 0.15x | €1.14 Million | €7.51 Million | €1.14 Million | ▲ +23.2% |
| 2003 | 0.12x | €1.01K | €8.19K | €1.01K | ▼ -99.9% |
| 2002 | 136.84x | €842.00K | €6.15K | €842.00K | ▲ +120030.1% |
| 2001 | 0.11x | €1.05 Million | €9.20 Million | €1.05 Million | ▼ -57.1% |
| 2000 | 0.27x | €894.00K | €3.37 Million | €894.00K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow